Personal information

Emails & domains

Verified email domains

Countries

Türkiye, Sweden, United States, Switzerland, United Kingdom

Activities

Collapse all

Employment (4)

Koç University: Istanbul, TR

2025-01-01 to present | Senior Scientist (Transplant Immunology Research Center of Excellence (TIREX))
Employment
Source: Self-asserted source
Can Altunbulakli

Lund University: Lund, SE

2021-04-05 to 2024-12-15 | Post-doctoral Scientist (Immunotechnology)
Employment
Source: Self-asserted source
Can Altunbulakli

Turkiye Saglik Enstituleri Baskanligi: Istanbul, TR

2020 to 2020 | Covid19 Diagnosis expert
Employment
Source: Self-asserted source
Can Altunbulakli

Northwestern Medicine: Chicago, Illinois, US

2018 to 2020 | Post-doctoral Researcher (Dermatology)
Employment
Source: Self-asserted source
Can Altunbulakli

Education and qualifications (3)

University of Zurich: Zurich, CH

2013 to 2018 | PhD (Immunology)
Education
Source: Self-asserted source
Can Altunbulakli

King's College London: London, London, GB

2011 to 2013 | MSc (Immunology)
Education
Source: Self-asserted source
Can Altunbulakli

Sabancı University: Istanbul, TR

2007 to 2011 | BSc (Bioengineering and Biological Sciences)
Education
Source: Self-asserted source
Can Altunbulakli

Funding (3)

Spatial mapping of myeloid cells in the tumor microenvironment of tonsillar cancer

2024-05 to present | Grant
Crafoordska stiftelsen (Lund, SE)
GRANT_NUMBER:

20240633
Source: Self-asserted source
Can Altunbulakli

Role of epigenetic regulation and inflammasome in epithelial barrier in asthma and atopic dermatitis

2017-10-01 to 2021-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.7160954
GRANT_NUMBER: 176190
Source: Self-asserted source
Can Altunbulakli via DimensionsWizard

Dysregulated epithelial barrier function in asthma

2014-10-01 to 2017-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5235175
GRANT_NUMBER: 156823
Source: Self-asserted source
Can Altunbulakli via DimensionsWizard

Works (25)

Regulation of immune response genes in the skin of allergic and clinically tolerant individuals exposed to p-phenylenediamine

Allergy: European Journal of Allergy and Clinical Immunology
2024 | Journal article
DOI: 10.1111/all.16031
EID:

2-s2.0-85183057013

Part of ISSN: 13989995 01054538
Contributors: Meisser, S.S.; Mitamura, Y.; Altunbulakli, C.; Bandier, J.; Opstrup, M.S.; Gadsbøll, A.-S.Ø.; Li, M.; Tan, G.; Akdis, M.; Akdis, C.A. et al.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier

Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children

Allergy: European Journal of Allergy and Clinical Immunology
2024 | Journal article
DOI: 10.1111/all.15832
EID:

2-s2.0-85166631006

Part of ISSN: 13989995 01054538
Contributors: Lunjani, N.; Ambikan, A.T.; Hlela, C.; Levin, M.; Mankahla, A.; Heldstab-Kast, J.I.; Boonpiyathad, T.; Tan, G.; Altunbulakli, C.; Gray, C. et al.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier

Single-cell analysis of myeloid cells in HPV<sup>+</sup> tonsillar cancer

Frontiers in Immunology
2023 | Journal article
DOI: 10.3389/fimmu.2022.1087843
EID:

2-s2.0-85147267106

Part of ISSN: 16643224
Contributors: Jimenez, D.G.; Altunbulakli, C.; Swoboda, S.; Sobti, A.; Askmyr, D.; Ali, A.; Greiff, L.; Lindstedt, M.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier

Targeted spatial proteomic analysis of CD8<sup>+</sup> T- and myeloid cells in tonsillar cancer

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1253418
EID:

2-s2.0-85178871476

Part of ISSN: 2234943X
Contributors: Altunbulakli, C.; Jimenez, D.G.; Askmyr, D.; Sobti, A.; Swoboda, S.; Greiff, L.; Lindstedt, M.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier

Single-cell analysis of myeloid cells in HPV<sup>+</sup> tonsillar cancer

bioRxiv
2022 | Other
DOI: 10.1101/2022.10.04.510291
EID:

2-s2.0-85143262713

Part of ISSN: 26928205
Contributors: Jimenez, D.G.; Altunbulakli, C.; Swoboda, S.; Sobti, A.; Askmyr, D.; Ali, A.; Greiff, L.; Lindstedt, M.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier
grade
Preferred source (of 2)‎

Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma

Allergy: European Journal of Allergy and Clinical Immunology
2021 | Journal article
DOI: 10.1111/all.14667
EID:

2-s2.0-85096964700

Part of ISSN: 13989995 01054538
Contributors: Wawrzyniak, P.; Krawczyk, K.; Acharya, S.; Tan, G.; Wawrzyniak, M.; Karouzakis, E.; Dreher, A.; Jakiela, B.; Altunbulakli, C.; Sanak, M. et al.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier
grade
Preferred source (of 2)‎

Environment‐dependent alterations of immune mediators in urban and rural south African children with atopic dermatitis

Allergy
2021-06-15 | Journal article
DOI: 10.1111/all.14974
Part of ISSN: 0105-4538
Part of ISSN: 1398-9995
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Allergy: European Journal of Allergy and Clinical Immunology
2020 | Journal article
DOI: 10.1111/all.14429
EID:

2-s2.0-85089280037

Part of ISSN: 13989995 01054538
Contributors: Radzikowska, U.; Ding, M.; Tan, G.; Zhakparov, D.; Peng, Y.; Wawrzyniak, P.; Wang, M.; Li, S.; Morita, H.; Altunbulakli, C. et al.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier
grade
Preferred source (of 2)‎

Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease

bioRxiv
2020 | Other
DOI: 10.1101/2020.05.14.090332
EID:

2-s2.0-85102603856

Part of ISSN: 26928205
Contributors: Radzikowska, U.; Ding, M.; Tan, G.; Zhakparov, D.; Peng, Y.; Wawrzyniak, P.; Wang, M.; Li, S.; Morita, H.; Altunbulakli, C. et al.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier
grade
Preferred source (of 2)‎

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas

Nature Communications
2020-12 | Journal article
DOI: 10.1038/s41467-020-15572-7
Part of ISSN: 2041-1723
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Tonsillar microbial diversity, abundance, and interrelations in atopic and non‐atopic individuals

Allergy
2020-04-19 | Journal article
DOI: 10.1111/all.14306
Part of ISSN: 0105-4538
Part of ISSN: 1398-9995
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Skin barrier damage after exposure to paraphenylenediamine

Journal of Allergy and Clinical Immunology
2020-02 | Journal article
DOI: 10.1016/j.jaci.2019.11.023
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL‐13

Allergy
2019-12 | Journal article
DOI: 10.1111/all.13935
Part of ISSN: 0105-4538
Part of ISSN: 1398-9995
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients

Nature Communications
2019-12 | Journal article
DOI: 10.1038/s41467-019-13751-9
Part of ISSN: 2041-1723
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Human bocaviruses and paediatric infections

The Lancet Child & Adolescent Health
2019-06 | Journal article
DOI: 10.1016/s2352-4642(19)30057-4
Part of ISSN: 2352-4642
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid

Journal of Allergy and Clinical Immunology
2019-06 | Journal article
DOI: 10.1016/j.jaci.2018.12.1018
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Bacterial secretion of histamine within the gut influences immune responses within the lung

Allergy
2019-05 | Journal article
DOI: 10.1111/all.13709
Part of ISSN: 0105-4538
Part of ISSN: 1398-9995
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells

Journal of Allergy and Clinical Immunology
2019-05 | Journal article
DOI: 10.1016/j.jaci.2018.11.016
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice

Allergy
2019-02 | Journal article
DOI: 10.1111/all.13619
Part of ISSN: 0105-4538
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps

Journal of Allergy and Clinical Immunology
2018 | Journal article
DOI: 10.1016/j.jaci.2018.01.046
EID:

2-s2.0-85044615878

Part of ISSN: 10976825 00916749
Contributors: Altunbulakli, C.; Costa, R.; Lan, F.; Zhang, N.; Akdis, M.; Bachert, C.; Akdis, C.A.
Source: Self-asserted source
Can Altunbulakli via Scopus - Elsevier
grade
Preferred source (of 2)‎

Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis

Journal of Allergy and Clinical Immunology
2018-11 | Journal article
DOI: 10.1016/j.jaci.2018.07.005
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients

Journal of Allergy and Clinical Immunology
2018-01 | Journal article
DOI: 10.1016/j.jaci.2017.02.038
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance

Journal of Allergy and Clinical Immunology
2017-11 | Journal article
DOI: 10.1016/j.jaci.2017.08.025
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

Journal of Allergy and Clinical Immunology
2016-10 | Journal article
DOI: 10.1016/j.jaci.2016.06.033
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎

CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier

Journal of Allergy and Clinical Immunology
2015-11 | Journal article
DOI: 10.1016/j.jaci.2015.05.006
Part of ISSN: 0091-6749
Source: Self-asserted source
Can Altunbulakli
grade
Preferred source (of 2)‎
How many people are using ORCID?